Hyperkalemia screening: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Hyperkalemia}} {{CMG}}; {{AE}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR According to the [guid...") |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Hyperkalemia}} | {{Hyperkalemia}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} [[Jogeet Singh Sekhon]] | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for [ | There is insufficient evidence to recommend routine screening for [hyperkalemia]. | ||
However potassium levels are routinely monitored in patients with chronic kidney diseases. | |||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for [ | There is insufficient evidence to recommend routine screening for [hyperkalemia]. | ||
==References== | ==References== | ||
Revision as of 21:22, 5 July 2018
|
Hyperkalemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hyperkalemia screening On the Web |
|
American Roentgen Ray Society Images of Hyperkalemia screening |
|
Risk calculators and risk factors for Hyperkalemia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jogeet Singh Sekhon
Overview
There is insufficient evidence to recommend routine screening for [hyperkalemia].
However potassium levels are routinely monitored in patients with chronic kidney diseases.
Screening
There is insufficient evidence to recommend routine screening for [hyperkalemia].